Brokerages Set Adaptive Biotechnologies Co. (NASDAQ:ADPT) PT at $9.50
Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 […]
Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 […]
